Hennings L, Bouchard R, Klempien I, Müller G, Rob P, Kujath P
Nephrologisches Zentrum an der Sana Klinik Lübeck, D-23562 Lübeck, Germany.
Mycoses. 2005;48 Suppl 1:78-83. doi: 10.1111/j.1439-0507.2005.01116.x.
Continuous ambulatory peritoneal dialysis (CAPD) is a widespread method of treatment used in approximately 10% of all patients suffering from terminal renal insufficiency. The main problem of this procedure is the increased risk of peritoneal infection. The incidence of such a peritonitis is quoted at one episode per 13-18.4 months of treatment. Candida peritonitis is a particularly severe form of CAPD peritonitis. This is a nosocomial infection with a high lethality rate of about 60%. The incidence of Candida peritonitis in CAPD patients amounts to approximately 5% of all intraabdominal infections and is on the increase. The authors describe a severe case of Candida peritonitis in a patient on CAPD. The therapeutic concept of this severe illness is illustrated.
